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As an adaptive response to the overloading with misfolded proteins in the endoplasmic
reticulum (ER), ER stress plays critical roles in maintaining protein homeostasis in the
secretory pathway to avoid damage to the host. Such a conserved mechanism is
accomplished through three well-orchestrated pathways known collectively as unfolded
protein response (UPR). Persistent and pathological ER stress has been implicated in a
variety of diseases in metabolic, inﬂammatory, and malignant conditions. Furthermore,
ER stress is directly linked with inﬂammation through UPR pathways, which modulate
transcriptional programs to induce the expression of inﬂammatory genes. Importantly, the
inﬂammation induced by ER stress is directly responsible for the pathogenesis ofmetabolic
and inﬂammatory diseases. In this review, we will discuss the potential signaling pathways
connecting ER stress with inﬂammation. We will also depict the interplay between ER
stress and inﬂammation in the pathogenesis of hepatic steatosis, inﬂammatory bowel
diseases and colitis-associated colon cancer.
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INTRODUCTION
The endoplasmic reticulum (ER) is an intracellular organelle
involving in folding of membrane and secreted proteins, synthe-
sis of lipids and sterols, and maintenance of intracellular calcium
homeostasis (Kleiner and Brunt, 2012; Milic and Stimac, 2012;
Tuyama and Chang, 2012; Wierzbicki and Oben, 2012; Ibrahim
et al., 2013). ER chaperones, such as glucose-regulated protein of
78 kDa (GRP78) and 94 kDa (GRP94, also termed as gp96) func-
tion as a quality control system that monitors newly synthesized
proteins, and ensures only correctly folded proteins to be trans-
ported out of ER (Yang and Li, 2005; Yang et al., 2007; Zhang et al.,
2011; Cnop et al., 2012; Chen et al., 2013; Lake et al., 2013). ER
stress takes place when unfolded or misfolded proteins accumu-
late in the ER lumen. In response to stress conditions, ER initiates
a series of unfolded protein response (UPR) signal transduction
pathways, including inositol-requiring enzyme 1 (IRE1), double-
stranded RNA-dependent protein kinase (PKR)-like ER kinase
(PERK), and activating transcription factor-6 (ATF6) pathways,
eventually, leading to changes in translational and transcriptional
programs (Urano et al., 2000; McGuckin et al., 2010; Schroder
and Sutcliffe, 2010; Hetz, 2012; Zha and Zhou, 2012). Cells
that undergo constant ER stress include immune cells such as
macrophages, plasma cells, and cells regulating metabolism such
as hepatocytes, pancreatic β-cells, adipocytes, andmucosal epithe-
lial cells. Those cells are sensitive to changes in the environments,
protein trafﬁc, and ER homeostasis (Ozcan et al., 2006; Eizirik
and Cnop, 2010; McAlpine et al., 2010; Schroder and Sutcliffe,
2010; Staron et al., 2010; Ye et al., 2010; Ji et al., 2011; Pfaffenbach
and Lee, 2011). While UPR is an adaptive response for cells to
restore ER homeostasis, severe or prolonged ER stress leads to cell
death and tissue damage. Accumulating evidence indicates that ER
stress is involved in various diseases including neurodegenerative
diseases, metabolic diseases, inﬂammatory diseases, cancer, and
so on.
Recently, ER stress has been recognized to induce inﬂamma-
tion (McGuckin et al., 2010; Eri et al., 2011; Garg et al., 2012;
Osorio et al., 2014; Shenderov et al., 2014). Interestingly, many
ER stress-associated diseases also display inﬂammatory pheno-
types (McGuckin et al., 2010; Eri et al., 2011; Garg et al., 2012;
Larrain and Rinella, 2012; Petrasek et al., 2012; Szabo and Csak,
2012;Wood,2012). Inﬂammatory cytokines released from stressed
cells may function as alarming or danger signals to communicate
with other cells or to recruit immune cells. While ER stress-
induced inﬂammation is essential for tissue remodeling, it can
cause tissue damage and contributes to the pathogenesis of many
inﬂammatory and metabolic diseases (Eizirik and Cnop, 2010;
McGuckin et al., 2010; Malhi and Kaufman, 2011; Cnop et al.,
2012; Garg et al., 2012; Zha and Zhou, 2012). Inﬂammation can
be induced directly by UPR pathways in stressed cells, or indi-
rectly through interaction with innate immune cells. Induction of
innate immunity is mediated by diverse families of Pattern Recog-
nition Receptors (PRRs) that recognize molecular “signature” of
the invading pathogens termed as pathogen associated molecu-
lar patterns (PAMPs; Takeuchi and Akira, 2010; Kawai and Akira,
2011). Additionally, innate immune cells can be activated by var-
ious endogenous ligands from damaged or dead cells. Toll-like
receptors (TLRs) are a major family of PRRs mainly expressed by
cells of the innate immune system. TLRs can initiate distinct innate
immune responses through recruitment of differentMyD88 adap-
tor family members. Currently, at least 13 TLRs have been cloned
in mammals, and each receptor is involved in the recognition of a
unique set of PAMPs. Studies from our group had demonstrated
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that GRP94 is a master molecular chaperone in the ER for TLRs.
Our results show that the function of most TLRs is dependent
on the integrity of GRP94 in the ER (Yang et al., 2007; Liu and
Li, 2008). In addition to TLRs, most nucleated cells are capable
of sensing and responding to pathogens inside the cytoplasm via
intracellular receptors including NOD-like receptors (NLRs) or
RIG-I-like receptor family members, which recognize bacteria or
viruses, respectively.
TLR activation triggers the recruitment of MyD88 via the Toll-
interleukin-1 receptor (TIR) domain, allowing for subsequent
recruitment of IL-1R associated kinase (IRAK) and tumor necro-
sis factor (TNF) receptor associated factor 6 (TRAF6), which
leads to the activation of both the NF-κB and JNK pathways.
In addition, TLRs are able to activate other signaling cascades
including the PI3K, p38, and ERK pathways. Activation of these
pathways leads to the expression of inﬂammatory cytokines such
as TNFα and IL-6. Recent progress demonstrates that inﬂamma-
somes, signaling complexes essential for IL-1β production, are also
involved in various inﬂammatory and metabolic diseases (Ting
et al., 2010; Davis et al., 2011; Stienstra et al., 2011; Henao-Mejia
et al., 2012a). Furthermore, pathogens can also induce ER stress
directly or indirectly in host cells (Joyce et al., 2009; Merquiol
et al., 2011; Muralidharan and Mandrekar, 2013; Blazquez et al.,
2014; Chan, 2014; Liu and Dudley, 2014; Smith, 2014). Com-
ponents of pathogen can interact with TLRs to inﬂuence cellular
stress response. Martinon et al. (2010) showed that stimulation
with TLR4 or TLR2 ligands activated the UPR sensor IRE1α
and its downstream target, X box-binding protein (XBP1). The
authors indicated that TLR-induced IRE1/XBP1 activation was
required for optimal and sustained production of proinﬂamma-
tory cytokines from macrophages. Notably, XBP1-deﬁcient mice
had reduced production of inﬂammatory mediators and signiﬁ-
cantly increased bacterial burden when infected with intracellular
pathogen Francisella tularensis. This novel ﬁnding suggests that
TLR and IRE1-XBP1 pathways acted in synergy to maximize
innate immune responses to pathogens. Interestingly, Woo et al.
(2009, 2012) found that the ATF4/CHOP branch of ER stress
signaling pathways was selectively suppressed by TLR 3 or 4
through a TRIF-dependent pathway. In mice pretreated with LPS,
a TLR4 ligand, ER stress-induced CHOP expression and apop-
tosis in macrophages, renal tubule cells, and hepatocytes were
suppressed. Accordingly, TLR engagement protected mice from
ER stress-induced renal dysfunction and hepatosteatosis. Results
from those studies suggest that host innate immune pathways
modulate ER-stress response to enhance inﬂammation, thereby
the host defense response, while suppress apoptosis pathways dur-
ing pathogen infections. In addition to the cross-talk of TLR and
UPR pathways, viral infection is frequently associated with ER
stress and UPR response because of viral protein synthesis and
assembly during viral life cycle. A striking example is hepatitis C
virus (HCV) infection, which is a strong risk factor for chronic
liver diseases and hepatocellular carcinoma. The ER stress and
inﬂammation induced by HCV contribute to chronic liver dis-
eases such as hepatic steatosis and cirrhosis though further studies
are needed (Joyce et al., 2009; Merquiol et al., 2011; Chan, 2014).
Since there are a number of excellent reviewers on ER stress
and UPR pathways (Bertolotti et al., 2000; Eizirik and Cnop, 2010;
McGuckin et al., 2010;Malhi and Kaufman, 2011; Pfaffenbach and
Lee, 2011; Cnop et al., 2012; Garg et al., 2012; Hetz, 2012; Logue
et al., 2013; Chan, 2014; Smith, 2014; Zhou and Liu, 2014), this
review will focus on ER stress-associated inﬂammation. ER stress
can initiate several signaling pathways that induce inﬂammation,
including ROS production, NF-κB pathway, JNK pathway, and
autophagy (McGuckin et al., 2010; Garg et al., 2012; Pagliassotti,
2012). Experimental evidence has indicated that all three major
UPR sensors are involved in inﬂammatory response. However,
the IRE1α pathway may play a dominant role in the upregulation
of inﬂammatory cytokines, chemokines, and tissue remodeling
molecules. The interaction between IRE1α and TRAF2 activates
NF-κB and JNK pathways, which are critical for the expression of
cytokines, chemokines, andother inﬂammatorymediators (Urano
et al., 2000; Pincus et al., 2010; Zhang et al., 2011; Lerner et al.,
2012; Oikawa et al., 2012; Tam et al., 2012; Upton et al., 2012;
Qiu et al., 2013). Our following discussion will be centered on
hepatic steatosis and inﬂammatory bowel diseases to illustrate the
interplay between ER stress and inﬂammation (Figure 1).
ER STRESS-INDUCED INFLAMMATION IN HEPATIC
STEATOSIS
As a vital organ for protein synthesis and detoxiﬁcation, liver is
especially susceptible to ER stress. Non-alcoholic fatty liver disease
(NAFLD), a spectrum of metabolic disorders ranging from steato-
sis (NAFL) to steatohepatitis (NASH) to cirrhosis, is the foremost
cause of non-alcoholic and non-viral liver-associated illness and
death in the US (Kleiner and Brunt, 2012; Larrain and Rinella,
2012; Milic and Stimac, 2012; Pagliassotti, 2012; Tuyama and
Chang, 2012; Wierzbicki and Oben, 2012; Ibrahim et al., 2013).
Hepatic steatosis or fatty liver can progress to NASH, character-
ized by progressive liver injury, inﬂammation, and ﬁbrosis. NASH
is also associated with obesity, type 2 diabetes, and liver cancer
development (Kleiner and Brunt, 2012; Tuyama and Chang, 2012;
Wood, 2012). While ER stress is important for maintaining liver
homeostasis, dysregulated ER stress contributes to the pathogen-
esis of various liver diseases. Accumulating evidence suggests that
the interaction between ER stress and inﬂammation also promote
liver steatosis and injury (Malhi and Kaufman, 2011; Cnop et al.,
2012; Pagliassotti, 2012; Lake et al., 2013).
ER STRESS AND HEPATIC STEATOSIS
Although clinical and experimental data implicate the involve-
ment of ER stress in liver diseases, the role and mechanism of
ER stress in liver diseases remain not fully understood. A number
of studies indicate that ER stress induces liver steatosis through
regulating lipid synthesis and inﬂammation (Malhi and Kauf-
man, 2011; Li et al., 2012; Pagliassotti, 2012;Wierzbicki and Oben,
2012). This notion is supported by mice carrying genetic muta-
tions of ER stress molecules, or by directly inducing ER stress
in vivo via administration of chemical reagents (Birkenfeld et al.,
2011; Ji et al., 2011; Zhang et al., 2011; Li et al., 2012; Nagara-
jan et al., 2012; Petrasek et al., 2012; Chen et al., 2013; Guo et al.,
2013; Hamano et al., 2013). For example, Tunicamycin (TM),
a widely used ER stress inducer, is a nucleoside antibiotics that
blocks N-linked glycosylation, causing accumulation of unfolded
or misfolded proteins in the ER lumen. Injection of TM into
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FIGURE 1 |The model of ER stress-associated inflammation.
Accumulation of misfolded proteins, genetic mutations of ER stress
molecules, or pharmacological compounds cause ER stress, which triggers
the activation of three major UPR sensors: IRE1α, PERK, and ATF6. Activation
of IRE1 pathway leads to the unconventional splicing of XBP-1, which control
the transcription of a group of UPR genes including GRP78 and GRP94. The
interaction of IRE1 andTRAF2 leads to NF-κB activation, which upregulates
survival genes. The signaling and transcription programs initiated by IRE1 and
other UPR pathways can restore the ER homeostasis. However, prolonged or
unresolved ER stress leads to inﬂammation. Sustained interaction of IRE1
andTRAF2 leads to NF-κB and JNK activation, which promote inﬂammatory
cytokine production and apoptosis. IRE1 is also involved in ER stress-induced
inﬂammasome activation and IL-1β production, which in turn induces other
inﬂammatory cytokines such as IL-6 and IL-8. In addition, TRAF6 can mediate
IRE1 ubiquitination, which is required for TLR mediated optimal inﬂammatory
cytokine production.
mice results in ER stress-mediated liver steatosis and lipogene-
sis (Zhang et al., 2011; Lee et al., 2012a,b). These ﬁndings indicate
the potential pathological role of ER stress in the development of
hepatic steatosis. On the other hand, obesity and liver steatosis
have been shown to induce ER stress. For instance, mice with high
fat feeding not only develop hepatic steatosis, insulin resistance,
and type 2 diabetes, but also exhibit ER stress markers in liver
and other tissues (Yang et al., 2010; Zhou and Liu, 2010; Birken-
feld et al., 2011). Thus ER stress and hepatic steatosis can form a
positive feedback loop to further amplify liver inﬂammation and
injury.
Several genetic strategies have been applied to tease out the
roles of ER stress and chaperones in liver steatosis. The ER chap-
erone protein GRP78 is a critical regulator of ER homeostasis and
stress responses, because it interacts and sequesters all major UPR
sensors (Ye et al., 2010; Pfaffenbach and Lee, 2011). Kammoun
et al. (2009) found that overexpression of GRP78 inhibited ER
stress-induced sterol regulatory element binding protein (SREBP)
expression and steatosis in the livers of obese (ob/ob) mice. Con-
versely, Ji et al. (2011) showed that GRP78 deletion led to liver fat
accumulation and steatosis. Using conditional GRP78 KO mouse
model, Ji et al. (2011) found that liver-speciﬁc deletion of GRP78
led to ER stress and apoptosis. These conditional KO mice also
displayed liver injury and steatosis. Furthermore, the authors
showed that liver-speciﬁc deletion of GRP78 exacerbated liver
injury and/or steatosis induced by alcohol, high-fat diet, drugs,
and toxins (Ji et al., 2011). These ﬁndings underscore the critical
role of ER tress and GRP78 in liver homeostasis and viability in
normal or disease conditions.
Results from Zhang et al. (2011) also demonstrate that ER is
not only important for protein quality control, but also criti-
cal for lipid synthesis and metabolism. ER stress induces hepatic
steatosis through upregulation of transcriptional factors essen-
tial for lipogenesis, including CCAAT/enhancer-binding protein β
(C/EBPβ), peroxisome proliferator-activated receptor γ (PPARγ),
and SREBP. Zhang et al. (2011) showed that the most conserved
UPR sensor IRE1α protected animals fromER stress-induced hep-
atic steatosis. To study the role of IRE1 in liver steatosis, the
authors generated a hepatocyte-speciﬁc IRE1α deﬁcient mouse
line. Deletion of IRE1α gene resulted in profound hepatosteatosis
and hypolipidemia in mice under conditions of ER stress induced
by proteasome inhibitor Bortezomib, or partial hepatectomy
(Zhang et al., 2011). Results from this study further demonstrated
that IRE1α represses the expression of transcriptional factors
in lipid metabolism pathways, including C/EBPβ, C/EBPδ, and
PPARγ (Zhang et al., 2011). The authors proposed that IRE1 is
required formaintaining hepatic lipid homeostasis under ER stress
conditions.
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THE INTERACTION OF IRE1 AND TRAF PROTEINS IN NF-κB ACTIVATION
IRE1α plays a critical role in transcription of inﬂammatory
genes due to its interaction with TRAF2, which promotes NF-
κB activation and inﬂammatory response. The TRAF family
proteins are intracellular adaptors that have been extensively
studied in the signaling pathways of TNFR or IL-1/TLR super-
families (Chung et al., 2002; Oganesyan et al., 2006; Bishop et al.,
2007). All TRAF family proteins (TRAF1-7) have the most con-
served TRAF domains in their carboxyl terminal region, which
involve in binding to different receptor cytoplasmic tails and
the formation of homo- or hetero-dimers between the family
members. In addition, all TRAF proteins except TRAF1 have
ring ﬁngers, which may function as E3 ubiquitin ligase. Ubiq-
uitination has been shown to play an important role in NF-κB
and other signal pathways (Chen, 2005; Pineda et al., 2007;
Ha et al., 2009). NF-κB is a homo or heterodimeric transcrip-
tion factor that binds to κB sites in the promoters of a large
number of genes involved in cell survival, inﬂammation, and
immune responses (Senftleben and Karin, 2002; Chen, 2005).
The activity of NF-κB is tightly regulated by members of the
IκB family. In the classical NF-κB pathway, receptor engagement
leads to the activation of the IκB kinase (IKK) complex, which
includes IKKα, IKKβ, and IKKγ (NEMO). The activated IKKs
phosphorylate IκBs such as IκBα, leading to subsequent ubiq-
uitination and degradation of IκBs. This releases NF-κB and
allows it to enter the nucleus and activate transcription of appro-
priate gene targets (Razani and Cheng, 2010; Dev et al., 2011).
NF-κB dimers are composed of the ﬁve Rel family members
that include NF-κB1 (p50), NF-κB2 (p52), RelA (p65), RelB,
and c-Rel. The function of each individual NF-κB molecule is
inﬂuenced by binding partners and other upstream molecules.
Several early studies suggested that UPR sensor IRE1α and sig-
naling molecule TRAF2 are required for activation of NF-κB in
response to ER stress-inducing agents, Thapsigargin and TM.
Kaneko et al. (2003) showed that ER stress-induced NF-κB acti-
vation was inhibited by a dominant-negative form of IRE1 or
TRAF2. Hu et al. (2006) also showed that ER stress-induced
NF-κB activation was impaired in IRE1α knockdown cells and
IRE1 KO MEFs. The authors further demonstrated that TRAF2
provided a critical link between UPR/IRE1 signaling and down-
stream IKK/NF-κB activation. Biochemical experiments showed
that in response to ER stress, IRE1α formed a signaling complex
with IKKs though the adapter protein TRAF2 (Hu et al., 2006).
Although those studies suggested that the interaction of IRE1,
TRAF2, and IKK plays an important role in ER stress-induced
NF-κB activation, how IRE1α activates the IKK complex is poorly
characterized. Furthermore, the function of IRE1 and TRAF2 in
ER stress-induced NF-κB activation in vivo needs to be further
explored.
ER STRESS-INDUCED INFLAMMASOME ACTIVATION
IL-1β and other IL-1 family members are major mediators in
inﬂammation. Production of mature IL-1β is regulated by at
least two signals: TLR-mediated transcriptional upregulation of
pro-IL-1β gene, and inﬂammasomes-mediated IL-1β matura-
tion (Cassel et al., 2009; Leemans et al., 2011; Rathinam et al.,
2012; Wen et al., 2012). An inﬂammasome is a multiprotein
signaling complex, composed of NOD-like protein (NLR) such
as NLRP3, the adaptor apoptosis-associated speck-like protein
containing a caspase recruitment domain (ASC), and caspase-1.
Activation of an inﬂammasome triggers autoproteolytic cleavage
of pro-caspase-1 into its active form, which subsequently pro-
cesses pro-IL-1β into its mature form (Cassel et al., 2009; Horng
and Hotamisligil, 2011; Menu and Vince, 2011; Vandanmagsar
et al., 2011). Although very diverse and unrelated stimuli are
found to trigger the activation of inﬂammasomes, the molecu-
lar mechanisms responsible for inﬂammasome activation remain
elusive.
Recent progress suggests that inﬂammasomes play a critical
role in a number of autoimmune and metabolic diseases. How-
ever, inﬂammasome activities have been shown to promote or
protect liver steatosis (Imaeda et al., 2009; Petrasek et al., 2012;
Szabo and Csak, 2012; Wood, 2012). Because of the important
role of both ER stress and inﬂammasome in inﬂammation, we
hypothesize that ER stress and inﬂammasome activity are inter-
connected during liver injury and steatosis. While several recent
studies demonstrated that ER stress induces pro-IL-1β mRNA
expression or NLRP3 inﬂammasome activation, whether or not
UPR pathways are involved in inﬂammasome activation remains
controversial (Lerner et al., 2012;Menu et al., 2012; Oslowski et al.,
2012; Shenderov et al., 2014). For instance, an early study from
Tschopp’s group suggested that ER stress triggered NLRP3 inﬂam-
masome activation in THP-1 cells, a macrophage/monocyte cell
line, in a mechanism that is independent of the classical ER stress
signaling pathways (Lerner et al., 2012;Menu et al., 2012; Oslowski
et al., 2012), whereas other groups suggested that IRE1α under
irremediable ER stress induced pro-IL-1β mRNA expression via
thioredoxin-interacting protein, which was also associated with
programmed cell death of pancreatic β cells. Further studies in
our and other laboratories are ongoing to elucidate the molecule
mechanisms by which ER stress induces NLRP3 inﬂammasome
activation and IL-1β production.
URP SIGNALING PATHWAYS INVOLVED IN LIVER INFLAMMATION
In addition to NF-κB pathway, IRE1/TRAF2 can activate other
transcription factors such as AP-1, which is also important for the
expression of inﬂammatory cytokines. PERK and ATF6 pathways
have also been reported to activate NF-κB (Yamazaki et al., 2009;
Nakajima et al., 2011; Tam et al., 2012); however, the mechanisms
of PERKorATF6-medaitedNF-κBactivation remain unknown. In
addition, activation of UPR leads to the generation of ROS, which
can induce inﬂammatory response. All theseUPRpathways poten-
tially contribute to liver steatosis and inﬂammation. However, the
relative contribution of each pathway is unclear. Furthermore,
NFALD progression is associated with increased apoptosis of hep-
atocytes. It has been suggested that severe or chronic ER stress
can cause cell death via induction of the CHOP pathway (Nishi-
toh, 2012; Han et al., 2013). The UPR pathways PERK and ATF6
branches are responsible for the activationof CHOP. IRE1pathway
can also induce cell death through either IRE1/TRAF2-mediated
JNK activation or direct interaction with Bac and Bak proapop-
totic proteins (Kato et al., 2012). It is possible that cell death under
severe ER stress conditions leads to sterile inﬂammation and tissue
damage in liver.
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INFLAMMATORY BOWEL DISEASES (IBD)
IBD, including Crohn’s disease (CD) and ulcerative colitis (UC),
is a complex intestinal tract disease involving various immune
cells, epithelial cells, and intestinal microﬂora (Strober et al., 2007;
Buonocore et al., 2010; Fritz et al., 2011; Papatriantafyllou, 2011;
Jostins et al., 2012). Genetic studies have identiﬁed many genes,
most related with immune response such as IL-10, TLR, NOD2,
and IL-23, autophagy and ER stress, that are associated with the
development of intestinal inﬂammation (Hugot et al., 2001; Van
Limbergen et al., 2007; Okazaki et al., 2008; Abraham and Cho,
2009; Sarra et al., 2010; Begue et al., 2011; Fritz et al., 2011). Intesti-
nal epithelial cells (IECs) are constantly exposed to gutmicroﬂora.
One of major functions of intestinal Paneth cells and goblet cells is
secretion of various factors essential for the intestinal homeosta-
sis and host defense. Furthermore, macrophages and DCs actively
produce inﬂammatory cytokines in response to translocated bac-
teria or bacterial components. Therefore, the intestinal system
is highly susceptible to ER stress. The interaction of innate and
microﬂora contributes to intestinal inﬂammation in both acute
and chronic colitis. Several excellent studies using genetic mutant
mice have highlight the critical role of ER stress in the pathogenesis
of colitis.
GRP94 IN GUT HOMEOSTASIS AND INFLAMMATION
Recent studies from others and our group have demonstrated
that ER HSP protein GRP94 is a critical chaperone for multi-
ple TLRs and integrins (Yang et al., 2007). To study the role of ER
chaperones in the intestinal homeostasis and inﬂammation, Liu
et al. (2013) generated conditional GRP94 KO mice and intesti-
nal tissue-speciﬁc GRP 94 KO mice. In the tamoxifen-inducible
GRP94 KO mice, deletion of GRP94 led to rapid weight loss, diar-
rhea, and ultimately death 12–14 days post-tamoxifen injection.
While not affecting embryo development, gut-speciﬁc deletion
of GRP94 was associated with postnatal death of mutant mice.
Pathological analysis demonstrated that GRP94 loss compromised
the intestinal barrier function with signiﬁcant intestinal dilata-
tion, edema and hemorrhage, and thickening of the intestinal
wall. The authors further demonstrated that GRP94 maintained
gut homeostasis through direct regulation of canonical Wnt-
signaling pathway. The results showed that GRP94 interacted
with mesoderm development (MesD), an ER chaperone essential
for the Wnt coreceptor low-density lipoprotein receptor-related
protein 6 (LRP6; Liu et al., 2013). The Wnt/β-catenin signaling
pathway has been shown previously to be critical for intesti-
nal homeostasis (Krausova and Korinek, 2014). Mechanistically,
GRP94 deletion impaired export of LRP6 from ER to the cell
surface, leading to profound loss of gut intrinsic Wnt signaling
and intestinal homeostasis. This ﬁnding underscores the impor-
tance of GRP94 in chaperoning the canonical LRP6/Wnt signal
pathway.
THE IRE1-XBP1 PATHWAY IN INTESTINAL HOMEOSTASIS
Several studies implicated UPR pathways in intestinal inﬂam-
mation and colitis. Bertolotti et al. (2001) showed that IRE1β
deﬁcient mice exhibited increased sensitivity to acute colitis
induced by dextran sodium sulfate (DSS). The authors found
that expression of IRE1β was restricted to the epithelium of
the gastrointestinal tract. DSS treatment led to elevated levels
of ER stress markers and increased severity of colitis in IRE1β
KO mice, compared with WT mice (Bertolotti et al., 2001). It
is unclear whether increased ER stress in IECs was caused by
espousing of gut epithelial cells to microﬂora or by intestinal
inﬂammation after DSS treatment. Nevertheless, these results
suggest that deletion of UPR sensor IRE1β disrupted intestinal
homeostasis in response to environmental challenge. IRE1 has
two forms, IRE1α and IRE1β, encoded by two distinct genes. It
is noteworthy that untreated IRE1β deﬁcient mice showed no
sign of intestinal inﬂammation histologically (Bertolotti et al.,
2001). One of reasons might be the redundant role of IRE1α and
IRE1β. However, whether speciﬁc deletion of IRE1α in the IECs
enhances the susceptibility to DSS-induced colitis has not been
reported.
The involvement of IRE1 pathway in colitis is also supported by
XBP1 conditional KO mice (Kaser et al., 2008). As a ribonuclease,
an important substrate of IRE1 is the mRNA for transcriptional
factor XBP1. Activated IRE1 splices the XBP1 mRNA by the
excision of a 26bp fragment via an unconventional splicingmecha-
nism, generating spliced XBP1 (XBP1s; Adolph et al., 2012; Upton
et al., 2012). XBP1s controls the transcription of a set of UPR
target genes, including chaperones, protein disulﬁde isomerases
(PDIs), and components of ERAD, essential for the maintenance
of ER function. Furthermore, XBP1 plays a critical role in the
development of highly secretory cells such as plasma cells and
pancreatic cells (Glimcher, 2010; Sha et al., 2011). Dr. Blumberg’s
group reported that mice with tissue-speciﬁc deletion of XBP1 in
IECs developed spontaneous enteritis and displayed increased sus-
ceptibility to DSS-induced colitis (Kaser et al., 2008). Kaser et al.
(2008) showed that mice deﬁcient in XBP-1 in intestinal tissues
displayed spontaneous intestinal inﬂammation characterized by
immune cell inﬁltration, loss of crypts, and ulceration. Strikingly,
deletion of XBP1 in IECs also resulted in the reduced number of
Paneth and goblet cells (Kaser et al., 2008; Adolph et al., 2013).
A major function of Paneth cells is to secret antimicrobial pep-
tides. Goblet cells are IECs that produce protective mucus in
the microbiota–intestine interface. The diminished function or
number of both cell types rendered these XBP1 deﬁcient mice
more susceptible to DSS-induced colitis. The authors also found
that XBP-1 deﬁcient intestinal tissues had increased expression
of ER stress mediators such as GRP78, ATF4, and CHOP (Kaser
et al., 2008). Enhanced ER stress may lead to more inﬂamma-
tion in response to gut microﬂora. In addition, upregulation
of CHOP may contribute to apoptosis of Paneth cells in XBP-1
deﬁcient mice. Thus, dysregulated ER stress in IEC compart-
ment induces intestinal inﬂammation and colitis. Kaser et al.
(2008) also found the association of XBP1 variants with both
CD and UC, indicating XBP1 as a genetic risk factor for human
IBD.
INFLAMMASOME ACTIVATION IN THE DEVELOPMENT OF COLITIS
The role of inﬂammasomes as well as their interaction withmicro-
biota in intestinal inﬂammation is an active area of research. Up
to now, a number of publications have painted a more complex
picture of inﬂammasomes in colitis and colitis-associated colon
cancer (Sands, 2007; Bauer et al., 2010, 2012; Zaki et al., 2010;
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Henao-Mejia et al., 2012b). Moreover, the interaction between ER
stress pathways and inﬂammasomes is still yet to be established.
Several studies showed that mice deﬁcient for inﬂammasome
components including NLRP3, ASC, and caspase-1 were highly
susceptible to acute colitis induced by DSS, indicating the pro-
tective role of inﬂammasome in acute colitis (Allen et al., 2010;
Dupaul-Chicoine et al., 2010; Hirota et al., 2011). However, Bauer
et al. (2010) showed that that defective in NLRP3 inﬂammasome
protected mice from DSS-induced acute colitis, indicating that
inﬂammasomes contribute to the development of colitis. Our
recent study showed that inﬂammasome activation promoted
the intestinal inﬂammation in IL-10 KO mice, which develops
chronic colitis resembling human IBD.We also found that inhibi-
tion of inﬂammasome activities with IL-1 receptor antagonist or
caspase-1 inhibitors suppressed intestinal inﬂammation (Zhang
et al., 2014). Our data further suggest that inﬂammasome-derived
IL-1β promoted Th17 phenotype in intestinal tissues. Those
results indicate that without inhibitory effects of IL-10, the inter-
action between inﬂammasomes and microbiota leads to intestinal
inﬂammation and the development of colitis.
ER STRESS AND INFLAMMATION IN COLITIS-ASSOCIATED COLON
CANCER
Inﬂammation contributes to tumor initiation and progression,
especially for colitis-associated colon cancer. Because of unregu-
lated growth and hypoxia environments, ER stress is associated
with tumor development. Depending on type or stage of tumor
development, ER stress can enhance or suppress tumor devel-
opment (Ghiringhelli et al., 2009; Allen et al., 2010; Hu et al.,
2011; Bruchard et al., 2013). Moreover, Mahadevan et al. (2011)
found that ER stress from stressed tumor cells could be trans-
mitted to other neighborhood cells via un-identiﬁed heat-stable
molecules. Conditioned media derived from cancer cells with ER
stress could induce ER stress markers such as XBP-1, GRP78, and
CHOP in macrophages, leading to production of inﬂammatory
molecules (Mahadevan et al., 2011). It is possible that this kind
of transmissible ER stress could amplify inﬂammation in tumor
microenvironments.
Because most studies on ER stress and tumor development
are focused on tumor-intrinsic stress pathways, research on ER
stress and inﬂammation in tumor microenvironments is lim-
ited so far. Using macrophage-speciﬁc KO mice, Morales et al.
(2014) showed that mice with macrophage-speciﬁc deletion
of GRP94/gp96 exhibited decreased colitis and inﬂammation-
associated colon cancer induced by DSS/AOM, with reduced
expression of inﬂammatory cytokines such as IL-6, IL-17, and
IL-23. These results demonstrate the macrophage-intrinsic role
of chaperone GRP96 in promoting colitis and inﬂammation-
associated colon tumorigenesis.
Similar to its controversial role in colitis, inﬂammasomes also
have a complex role in tumor development. A study by Allen et al.
(2010) showed that NLRP3-deﬁcient mice were more sensitive
Table 1 | A list of diseases linked to dysregulated ER stress.
Diseases Reference
Metabolic diseases
Hepatic steatosis Malhi and Kaufman (2011), Zhang et al. (2011)
Type 2 diabetes mellitus Papa (2012), Biden et al. (2014)
Obesity Kawasaki et al. (2012), Tripathi and Pandey (2012)
Atherosclerosis McAlpine andWerstuck (2013), Zhou andTabas (2013)
Autoimmune diseases
Arthritis Yoo et al. (2012), Qiu et al. (2013), Savic et al. (2014)
Inﬂammatory diseases Kaser et al. (2008), Liu et al. (2013)
Chronic pulmonary diseases Blohmke et al. (2012), Blumental-Perry (2012)
Neurodegenerative diseases
Alzheimer’s disease Cornejo and Hetz (2013), Li et al. (2014)
Parkinson’s disease Bellucci et al. (2011), Vidal et al. (2012), Mercado et al. (2013)
Multiple sclerosis Cunnea et al. (2011), McMahon et al. (2012)
Pathogen infections
Viral infection Chan (2014), Tesh (2012), Blazquez et al. (2014)
Bacterial infection Martinon et al. (2010), Lee et al. (2013)
Tumor
Breast cancer Martin-Perez et al. (2014), Zheng et al. (2014)
Colon cancer Hardy et al. (2012), Morales et al. (2014)
Leukemia and lymphomas Mahoney et al. (2013), Kharabi Masouleh et al. (2014)
Hepatocellular carcinoma Shuda et al. (2003), Tang et al. (2012), Chen et al. (2013)
Pancreatic cancer Kubisch and Logsdon (2008), Romero-Ramirez et al. (2009)
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to colorectal tumorigenesis. The authors found that mice deﬁ-
cient for NLRP3 inﬂammasome components including NLRP3,
ASC or caspase-1 had severe colitis and increased tumorigenesis
in AOM/DSS colon cancer model. But NLRC4 KO mice displayed
similar incidence of colitis-associated colon cancer as WT mice.
The authors further demonstrated that NLRP3-inﬂammasome
activation in bone marrow-derived cells was critical for the tumor
suppression. In contrast, Hu et al. (2011) found that caspase-
1 KO and NLRC4 KO mice, but not NLRP3 KO mice, had
increased tumorigenesis in the AOM/DSS colon cancer model.
Furthermore, NLR6 and NLR12 also have been shown to suppress
tumor development in AOM/DSS colon cancer model (Chen and
Nunez, 2011; Chen et al., 2011). A possible explanation is that
inﬂammasome-processed IL-1 and IL-18 signaling in IECs pro-
vides protection against apoptosis of gut epithelial cells. Those
studies imply that the inﬂammasomes may promote or suppress
colon cancer development depending on experimental conditions,
possibly gut microﬂora.
ER STRESS AND INFLAMMATION IN OTHER DISEASES
ER stress-induced inﬂammation is also associated with other
metabolic (Kawasaki et al., 2012; Papa, 2012; Tripathi and Pandey,
2012; McAlpine andWerstuck, 2013; Zhou and Tabas, 2013; Biden
et al., 2014), inﬂammatory (Blohmke et al., 2012; Blumental-Perry,
2012; Yoo et al., 2012; Qiu et al., 2013; Savic et al., 2014), neu-
rodegenerative diseases (Bellucci et al., 2011; Cunnea et al., 2011;
McMahon et al., 2012; Vidal et al., 2012; Cornejo and Hetz, 2013;
Mercado et al., 2013; Li et al., 2014), pathogen infections (Marti-
non et al., 2010; Merquiol et al., 2011; Tesh, 2012; Lee et al., 2013;
Blazquez et al., 2014; Chan, 2014), and cancer (Shuda et al., 2003;
Kubisch and Logsdon, 2008; Romero-Ramirez et al., 2009; Hardy
et al., 2012; Tang et al., 2012; Chen et al., 2013; Mahoney et al.,
2013; KharabiMasouleh et al., 2014;Martin-Perez et al., 2014; Shi-
modaira et al., 2014; Zheng et al., 2014). While this review focuses
on liver steatosis and inﬂammatory bowl diseases, Table 1 listed
various diseases where pathogenesis has directly or indirectly been
linked to ER stress.
CONCLUSION AND PERSPECTIVES
ER stress functions as an adaptive response to maintain cell
homeostasis and survival when normal protein or lipid synthe-
sis and metabolism are perturbed. Emerging evidence indicates
that ER stress is also closely associated with inﬂammation, in
addition to its classic role in protein quality control. We pro-
pose that the IRE1/TRAF2 axis represents a major pathway to
link ER stress with key transcription factors such as NF-κB
that controls the expression of inﬂammatory cytokine genes. We
also speculate that the interaction between UPR pathways and
inﬂammasomes provides another link between ER stress and
inﬂammation. While the activation of UPR pathways can lead
to resolving the ER stress and achieving new protein homeostasis,
prolonged and severe ER stress can result in cell death and tis-
sue damage, contributing to the pathogenesis of various diseases.
In both scenarios, inﬂammation can be induced in stressed cells
and surrounding cells. In a broad term, inﬂammatory diseases
such as IBD and hepatic steatosis are the results of interaction
amongst ER stress, inﬂammatory cytokines, metabolism, and
gut microﬂora (Machado and Cortez-Pinto, 2012). Similarly, ER
stress and inﬂammation can promote or inhibit the development
of colitis-associated cancer depending on genetic background,
environments, and intestinal microﬂora. A better understand-
ing of ER stress and inﬂammation may lead to identiﬁcation of
potential therapeutic targets for the treatment of inﬂammatory
and metabolic diseases as well as cancer.
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